D546 Task 1 Hospital Merger Analysis Example

An Adult Hospital and a Children's Hospital Three Miles Apart: Governance, Finance, Ethics and Regulation in a Composite Merger

Student Name

Leavitt School of Health, Western Governors University

D546: Healthcare Policy and Governance, Task 1

Course Instructor

Month Day, Year

An Adult Hospital and a Children's Hospital Three Miles Apart: Governance, Finance, Ethics and Regulation in a Composite Merger

The Two Organizations

Northgate Medical Center is a 410-bed adult hospital, part of a regional system, with a Level II trauma center, cardiac surgery and a large outpatient network. Linden Children's Hospital is a 130-bed independent nonprofit pediatric hospital three miles away, with the region's only pediatric intensive care unit and a strong research program funded partly by philanthropy. Linden has lost money in four of the past five years, largely because 58% of its patient days are paid by Medicaid, whose rates fall well below the cost of care. Northgate's system has offered to make Linden a subsidiary, with Linden keeping its name and pediatric mission. Both boards have signed a letter of intent. This analysis identifies one administrative and one financial challenge unique to this merger, weighs the ethical concerns, explains the regulatory requirements and assesses the business implications.

Administrative Challenge: Two Opposite Governance Models

The central administrative challenge is aligning two governance structures that work in opposite ways. Northgate is governed centrally: the system board sets strategy, the system executive team makes most operating decisions, and Northgate's local leaders carry them out. Linden is governed from the ground up: its independent board relies heavily on physician-led committees, department chiefs control their own budgets and major decisions are made by consensus among clinical leaders. At Linden, a new service line is proposed by physicians and approved by committees; at Northgate, it is proposed by the executive team and approved by the system board.

This matters because the merger agreement promises Linden a protected pediatric mission while placing it under a system that makes decisions centrally. If Linden's physicians lose the authority they are used to, the hospital risks losing the specialists who are hardest to replace; pediatric subspecialists are scarce, and many could find positions elsewhere. If the system leaves Linden's structure untouched, it cannot coordinate services such as imaging, laboratory and adolescent transitions of care that are supposed to justify the merger. The recommended approach is a subsidiary board for Linden with defined reserved powers: the system board keeps authority over capital spending and debt, while Linden's board and medical staff keep authority over pediatric clinical programs, research priorities and physician appointments, with a joint committee for shared services.

Financial Challenge: A Medicaid-Heavy Hospital With Restricted Funds

The central financial challenge is integrating the finances of a hospital whose payer mix and funding sources differ sharply from the system's. Linden's revenue depends on Medicaid and philanthropy; Northgate's on commercial insurance and Medicare. The two use different budgeting methods, Northgate incremental budgeting on a calendar year and Linden a zero-based budget on a July fiscal year, and different cost accounting systems, so their reported costs per case cannot be compared without rebuilding them on a common basis.

The most sensitive part is Linden's $40 million in donor-restricted funds, most given for pediatric research and specific programs such as child life and the neonatal follow-up clinic. Donor restrictions are legal obligations: the funds may only be used for the purposes the donors named, and the state attorney general, who oversees charitable assets, will review how the merger treats them. Any perception that restricted pediatric gifts could support adult services would also damage Linden's fundraising. The recommendation is to keep Linden's restricted funds in separate accounts under Linden's board, align the fiscal year and chart of accounts within 18 months, and adopt a single cost accounting system so that pediatric services can be evaluated on accurate costs rather than allocations designed for adult care.

Ethical Concerns

Three ethical concerns stand out. The first is access for children covered by Medicaid. A system facing financial pressure could be tempted to reduce unprofitable pediatric services, which would fall hardest on low-income families with no nearby alternative. Justice requires that the merger protect those services, and the recommended governance model helps by giving Linden's board control over pediatric programs. The second is honesty with donors and the community: gifts made to an independent children's hospital must be used as promised, and the community should be told plainly what will change and what will not. The third is fairness to employees. Mergers often bring consolidation of administrative roles, and employees deserve early, truthful communication, fair selection processes and support for those whose jobs change. Evidence suggests that patients can notice when a merger is managed poorly: a study of hospitals acquired by other hospitals or systems found a modest decline in patient experience scores after acquisition, with no significant change in readmission or mortality rates (Beaulieu et al., 2020).

Regulatory Compliance

Privacy and security. Before the merger closes, the two hospitals remain separate covered entities under HIPAA. Due diligence must use de-identified or aggregate data where possible, and any sharing of protected health information must be limited to the minimum necessary and covered by appropriate agreements. After closing, the organizations must decide whether to operate as affiliated covered entities, update their notices of privacy practices, align security policies and plan record integration with access controls, so that staff at each hospital see only the records they need.

Accreditation and licensure. Each hospital must notify its accreditor of the change in ownership and maintain its accreditation through the transition; any integration of services such as laboratory or pharmacy must preserve compliance with accreditation standards. The state health department must approve the change in ownership of Linden's license, and both hospitals must update their Medicare enrollment.

Antitrust. Depending on its size, the transaction may require premerger notification to the Federal Trade Commission and the Department of Justice, which can investigate mergers that may reduce competition (Federal Trade Commission, n.d.). Because Northgate and Linden mostly provide different services, the risk that the merger reduces direct competition is lower than for two general hospitals. Regulators may still examine whether the combined system could use its control of the only pediatric intensive care unit in the region to negotiate higher prices for adult services. Research on hospital mergers found that prices rose by more than 6% when merging hospitals were five miles apart or less, but not when they were far apart (Cooper et al., 2019), so the hospitals' closeness will draw attention.

Business Implications

For Linden, the merger offers financial stability, access to capital for a new pediatric intensive care unit and lower costs for supplies, information technology and insurance. For Northgate, it adds pediatric capability that strengthens its position with employers and insurers, supports its adult congenital heart program and creates smoother transitions for adolescents with chronic illness. The risks are real: loss of pediatric specialists if governance is mishandled, loss of donor support if restricted funds are handled poorly, regulatory delay and the cost of integrating systems. On balance, the merger is sound if the reserved powers, separate restricted funds and communication plan recommended here are written into the definitive agreement, so that the protections for Linden's mission are enforceable rather than promised.

References

Beaulieu, N. D., Dafny, L. S., Landon, B. E., Dalton, J. B., Kuye, I., & McWilliams, J. M. (2020). Changes in quality of care after hospital mergers and acquisitions. New England Journal of Medicine, 382(1), 51-59. https://doi.org/10.1056/NEJMsa1901383

Cooper, Z., Craig, S. V., Gaynor, M., & Van Reenen, J. (2019). The price ain't right? Hospital prices and health spending on the privately insured. The Quarterly Journal of Economics, 134(1), 51-107. https://doi.org/10.1093/qje/qjy020

Federal Trade Commission. (n.d.). Premerger notification and the merger review process. https://www.ftc.gov/advice-guidance/competition-guidance/guide-antitrust-laws/mergers/premerger-notification-merger-review-process